These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32718901)

  • 1. Cardiac Magnetic Resonance Late Gadolinium Enhancement Imaging in Arrhythmic Risk Stratification.
    Nucifora G; Selvanayagam JB
    Heart Lung Circ; 2020 Sep; 29(9):1268-1269. PubMed ID: 32718901
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score.
    Todiere G; Nugara C; Gentile G; Negri F; Bianco F; Falletta C; Novo G; Di Bella G; De Caterina R; Zachara E; Re F; Clemenza F; Sinagra G; Emdin M; Aquaro GD
    Am J Cardiol; 2019 Oct; 124(8):1286-1292. PubMed ID: 31447011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies.
    Peretto G; Sala S; Lazzeroni D; Palmisano A; Gigli L; Esposito A; De Cobelli F; Camici PG; Mazzone P; Basso C; Della Bella P
    Heart Lung Circ; 2020 Sep; 29(9):1356-1365. PubMed ID: 32299760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Signal Intensity on T2-Weighted Cardiovascular Magnetic Resonance Imaging Predicts Life-Threatening Arrhythmic Events in Hypertrophic Cardiomyopathy Patients.
    Hen Y; Takara A; Iguchi N; Utanohara Y; Teraoka K; Takada K; Machida H; Takamisawa I; Takayama M; Yoshikawa T
    Circ J; 2018 Mar; 82(4):1062-1069. PubMed ID: 29467354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy.
    Hen Y; Tsugu-Yagawa M; Iguchi N; Utanohara Y; Takada K; Machida H; Takara A; Teraoka K; Inoue K; Takamisawa I; Takayama M; Yoshikawa T
    Heart Vessels; 2018 Jan; 33(1):49-57. PubMed ID: 28766047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merging strain-echo measurements with late gadolinium enhancement at cardiac MRI: An upcoming chance for advanced functional assessment of fibrosis in hypertrophic cardiomyopathy?
    de Gregorio C; Di Bella G
    Int J Cardiol; 2016 Jan; 203():632-4. PubMed ID: 26590884
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy.
    Doesch C; Tülümen E; Akin I; Rudic B; Kuschyk J; El-Battrawy I; Becher T; Budjan J; Smakic A; Schoenberg SO; Borggrefe M; Papavassiliu T
    Sci Rep; 2017 Jul; 7(1):6336. PubMed ID: 28740148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
    Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy.
    Yano T; Oshima H; Miki T; Tanaka M; Muranaka A; Osanami A; Takahashi F; Miura T
    Int J Cardiol; 2016 Jan; 203():136-7. PubMed ID: 26512827
    [No Abstract]   [Full Text] [Related]  

  • 12. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
    Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
    Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
    Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
    Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed contrast enhancement CMR imaging in apical hypertrophic cardiomyopathy.
    Jassal DS; Chaithiraphan V; Neilan TG; Cury RC
    Int J Cardiol; 2006 Nov; 113(2):e56-7. PubMed ID: 16769137
    [No Abstract]   [Full Text] [Related]  

  • 15. Right ventricular thickening and extensive late gadolinium enhancement in a patient with rare case of isolated cardiac sarcoidosis and initially negative biopsy.
    Ueberham L; Paetsch I; Jahnke C; Klingel K; Dinov B
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1427-1428. PubMed ID: 29029004
    [No Abstract]   [Full Text] [Related]  

  • 16. Late Gadolinium Enhancement-Dispersion Mapping: A New Magnetic Resonance Imaging Technique to Assess Prognosis in Patients With Hypertrophic Cardiomyopathy and Low-Intermediate 5-Year Risk of Sudden Death.
    Aquaro GD; Grigoratos C; Bracco A; Proclemer A; Todiere G; Martini N; Habtemicael YG; Carerj S; Sinagra G; Di Bella G
    Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010489. PubMed ID: 32539460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
    Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
    Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy with apical aneurysm.
    Sun JP; Yang XS; Wong KT; Yu CM
    Int J Cardiol; 2015 Apr; 184():394-396. PubMed ID: 25745991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.